Vecabrutinib Uses, Dosage, Side Effects and more
Vecabrutinib is under investigation in clinical trial NCT03037645 (Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers).
| Trade Name | Vecabrutinib |
| Generic | Vecabrutinib |
| Type | |
| Formula | C22H24ClF4N7O2 |
| Weight | Average: 529.92 Monoisotopic: 529.1616134 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
